Pure Global

CK-MB Assay (CK-MB Assay ) - India CDSCO Medical Device Registration

CK-MB Assay (CK-MB Assay ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000207_be688de8e7d4c353540450cb49ae31d3_dfc1c7891886838c6ff6b804e4cad709. This device is marketed under the brand name CLIA. The license holder is Rapid House, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
CK-MB Assay (CK-MB Assay )
UID: IMP/IVD/2023/000207_be688de8e7d4c353540450cb49ae31d3_dfc1c7891886838c6ff6b804e4cad709

Brand Name

CLIA

License Holder

Rapid House

Device Class

Class B

Approving Authority

CDSCO

Product Information

CK-MB Assay (CLIA) is for the in vitro quantitative determination of creatine kinase MB (CLIA) in human serum and plasma

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing